A detailed history of Two Sigma Securities, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 71,452 shares of OCGN stock, worth $118,610. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,452
Previous 30,574 133.7%
Holding current value
$118,610
Previous $17,000 588.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.5 - $1.83 $20,439 - $74,806
40,878 Added 133.7%
71,452 $117,000
Q4 2023

Feb 14, 2024

SELL
$0.36 - $0.57 $22,019 - $34,864
-61,165 Reduced 66.67%
30,574 $17,000
Q3 2023

Nov 14, 2023

BUY
$0.4 - $0.62 $13,321 - $20,648
33,304 Added 56.99%
91,739 $36,000
Q2 2023

Aug 14, 2023

BUY
$0.45 - $0.88 $26,295 - $51,422
58,435 New
58,435 $31,000
Q4 2022

Feb 14, 2023

SELL
$1.11 - $1.87 $20,016 - $33,721
-18,033 Reduced 62.78%
10,691 $13,000
Q3 2022

Nov 14, 2022

BUY
$1.75 - $3.1 $50,267 - $89,044
28,724 New
28,724 $51,000
Q2 2022

Aug 15, 2022

SELL
$1.83 - $3.45 $32,456 - $61,189
-17,736 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.34 - $4.72 $24,366 - $49,149
-10,413 Reduced 36.99%
17,736 $59,000
Q4 2021

Feb 14, 2022

BUY
$4.38 - $15.67 $123,292 - $441,094
28,149 New
28,149 $128,000
Q1 2021

May 17, 2021

SELL
$1.66 - $15.81 $85,247 - $811,906
-51,354 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$0.28 - $2.6 $14,379 - $133,520
51,354 New
51,354 $94,000
Q1 2020

May 15, 2020

SELL
$0.26 - $0.73 $3,577 - $10,045
-13,761 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$0.27 - $2.19 $3,715 - $30,136
13,761 New
13,761 $7,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $359M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.